pubmed-article:9035984 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9035984 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
pubmed-article:9035984 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
pubmed-article:9035984 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:9035984 | lifeskim:mentions | umls-concept:C0205160 | lld:lifeskim |
pubmed-article:9035984 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:9035984 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:9035984 | pubmed:dateCreated | 1997-2-24 | lld:pubmed |
pubmed-article:9035984 | pubmed:abstractText | we have realized an open study in a population of chronic schizophrenic inpatients treated with clozapine. The purpose of this study was to investigate the clinical response and the effect of extrapyramidal symptoms of this atypical antipsychotic. | lld:pubmed |
pubmed-article:9035984 | pubmed:language | fre | lld:pubmed |
pubmed-article:9035984 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9035984 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9035984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9035984 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9035984 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9035984 | pubmed:issn | 0013-7006 | lld:pubmed |
pubmed-article:9035984 | pubmed:author | pubmed-author:BougerolTT | lld:pubmed |
pubmed-article:9035984 | pubmed:author | pubmed-author:LançonCC | lld:pubmed |
pubmed-article:9035984 | pubmed:author | pubmed-author:AuquierPP | lld:pubmed |
pubmed-article:9035984 | pubmed:author | pubmed-author:LlorcaP MPM | lld:pubmed |
pubmed-article:9035984 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9035984 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:9035984 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9035984 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9035984 | pubmed:pagination | 287-92 | lld:pubmed |
pubmed-article:9035984 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:meshHeading | pubmed-meshheading:9035984-... | lld:pubmed |
pubmed-article:9035984 | pubmed:articleTitle | [Clinical effects of clozapine: effect on negative symptoms]. | lld:pubmed |
pubmed-article:9035984 | pubmed:affiliation | Service de Psychiatrie d'Adultes, CHU Sainte-Marguerite, Marseille. | lld:pubmed |
pubmed-article:9035984 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9035984 | pubmed:publicationType | English Abstract | lld:pubmed |